The science behind Emenla.

What the published evidence says about endometriosis, the years it takes to be believed, and what a record kept in your own words can do. Every claim on this page has a source.

What the evidence says · WHO, ESHRE, NICE and ACOG

A common disease, a long wait, and a diagnosis that no longer needs surgery.

Endometriosis affects roughly one in ten women and girls of reproductive age, around 190 million people worldwide.[1] The lesions can sit on the ovaries, the peritoneum, the bowel or the bladder, and the pain they cause does not track their size.[10][11]

The wait for a name is long. Studies across Europe and the United Kingdom put the delay between first symptoms and a diagnosis at several years, commonly between four and eleven,[5][7][8] and a large part of that delay is symptoms being treated as normal, by the person and by the clinician in front of her.[6][15]

The diagnosis itself has changed. The European guideline of 2022 no longer requires laparoscopy as the first step,[2] a position specialists had argued for as a call to action in 2019,[13] and in 2026 the American College of Obstetricians and Gynecologists said a clinical diagnosis made from symptoms, history and an examination is enough to begin treatment.[4] The history is the evidence. That is what a record is for.

10%

of women and girls of reproductive age are affected worldwide, by the World Health Organization's estimate. [1]

190 million

people living with endometriosis, the same estimate. [1]

4 to 11 years

the delay between first symptoms and a diagnosis that studies commonly report. [5][7][8]

No surgery

is required first: a clinical diagnosis from symptoms, history and examination is enough to begin treatment. [2][4]

What that means for a record.

Your words first.

People with endometriosis struggle to make their pain understood in the clinic; the language available to describe it fails them, and the failure costs time.[14][15] Emenla keeps the sentence you actually wrote and prints the clinical term beside it, with its source, so the match can be checked at a glance.

Counted, not concluded.

The guidelines describe endometriosis pain by its pattern over time: cyclical, chronic, with periods, with sex, with the bowel.[2][3] Emenla counts what you logged against the periods you logged and reports the count. The one estimate it shows is a range for your next period, worked out from the starts you logged and labelled as an estimate.

Honest by design.

Emenla is a record-keeping app, not a medical device. It has not been studied in a trial. This page cites the evidence about the disease and about what helps a diagnosis. It makes no claim about what the app does for your health.

Beyond the record: what we have not done.

Where a device company would show you its validation study, we can only show you the standard we hold ourselves to. The clinical terms in Emenla come from three published guidelines, each cited inside the app.[2][3][4] The quality-of-life and cost burden of the disease is documented in large multicentre studies.[9][17] Health data is special category data under GDPR, which is why your record is kept on your phone.[21]

Read the sources

Emenla has not been studied in a clinical trial. It does not diagnose, treat or predict any condition, and nothing on this page is a claim about the app's effect on your health.

The evidence base

Emenla is built on published guidelines and on how people with endometriosis describe their pain. Here is what the evidence says about the disease, the delay, and the diagnosis, and what the app does with it.

Part 1. The disease

What endometriosis is, and why the pain does not track the lesion

The disease

Part 2. The delay

Why it takes years to be believed

The delay

Part 3. The diagnosis

What the guidelines changed, and what a record is for

The diagnosis

1. The disease: what endometriosis is

Tissue like the lining of the womb, growing where it should not, in roughly one in ten women and girls of reproductive age.


Lesions outside the uterus

Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside it. The World Health Organization describes it as chronic and often painful, and estimates that it affects about 10% of women and girls of reproductive age worldwide, around 190 million people.[1] The lesions most often sit on the ovaries and on the peritoneum, the lining of the pelvis, but they can involve the bowel, the bladder and, rarely, sites beyond the pelvis.[10][12] The disease is inflammatory and depends on oestrogen, which is why it tends to appear after the first period and quieten after the menopause.[10]

A systemic disease, not a pelvic one

For a long time endometriosis was described as a disease of the pelvis. A 2021 review in The Lancet argues that it is better understood as a systemic disease: it changes metabolism, immune signalling and the processing of pain far from the lesions themselves, and it is associated with fatigue, anxiety and low mood.[11] The New England Journal of Medicine review of 2020 makes a similar point from the clinic: the presentations vary widely, from severe period pain to bowel symptoms to infertility with little pain at all.[10]

Pain does not track the lesion

The amount of disease found at surgery does not correspond to how much it hurts. Small, superficial lesions can cause severe pain, and extensive disease is sometimes found in people who report none.[10][11] Part of the explanation is that persistent pain changes the nervous system itself, a process called central sensitisation, so that pain can outlast and spread beyond its original source.[11][12] This is why the story matters as much as the scan: what a person reports, when, and in what pattern carries information that imaging cannot.[12]

An old disease with a short modern history

Descriptions that match endometriosis appear in medical writing going back centuries, under other names and with other explanations.[19] The modern account begins in 1927, when John Sampson proposed that menstrual tissue flowing backwards through the fallopian tubes could implant in the pelvis.[20] Retrograde menstruation happens in most women, though, and only some develop the disease, so no single theory explains every lesion. Genetics, immunity and the hormonal environment all play a part, and the causes are still debated.[18]

2. The delay: why it takes years to be believed

The interval between the first symptoms and a name for them is measured in years, and much of it is spent not being believed.


Four to eleven years

Studies of the delay between first symptoms and a diagnosis keep returning the same order of magnitude. A 2024 scoping review of the published research put the range at roughly four to eleven years, depending on the country and the method.[5] In Austria and Germany, a multicentre study of 171 patients found a median of 10.4 years, and 74% had been given a different explanation first.[7] In the United Kingdom, a specialist centre reported a median of 8 years, with a quarter of patients waiting 14 years or more, and concluded that the delay had not improved in two decades.[8]

Normalised at both ends

Why so long? In a qualitative study of women in the UK, Ballard and colleagues found that the delay had two halves. First the person normalises the pain: periods are expected to hurt, and the people around her say so. Then the clinician does the same, so the symptoms are read as ordinary, or put down to something else, and the consultation ends without a plan.[6] Denny's interviews describe the same experience from the inside: being told repeatedly that nothing is wrong, and beginning to doubt the pain oneself.[15] The Austrian and German study found that normalisation of period pain, by patients and by their mothers, measurably lengthened the delay.[7]

The language of pain

Pain that is hard to describe is harder to act on. Bullo's analysis of how people with endometriosis talk about their pain found that they reach for metaphor because the plain vocabulary of the clinic does not fit: being stabbed, being set on fire, something pulling from the inside.[14] Those descriptions carry information about the kind of pain and its pattern, but they are easy to dismiss as exaggeration, and the gap between the two vocabularies costs credibility and time.[14][15]

What the wait costs

The burden is measurable. Across sixteen centres in ten countries, Nnoaham and colleagues found that each affected woman lost on average 10.8 hours of work a week, mostly through working less effectively while in pain, after a delay of 6.7 years between symptoms and a surgical diagnosis.[9] In referral centres across ten countries, Simoens and colleagues put the average annual cost at 9,579 euros per person, two thirds of it lost productivity, a burden they describe as similar to diabetes, Crohn's disease and rheumatoid arthritis.[17] The Endometriosis Health Profile, a questionnaire built in 2001 to measure quality of life in this condition specifically, exists because the general instruments missed what the disease does to daily life.[16]

3. The diagnosis: what the guidelines changed

Three guidelines now say that a diagnosis can begin with the history. That is what a record is for.


A call to action, 2019

For decades the definitive diagnosis was surgical: laparoscopy, with the lesions seen and, ideally, confirmed under a microscope. In 2019 a group of specialists led by Agarwal argued, in a paper they called a call to action, that waiting for surgery was itself the delay, and that a clinical diagnosis made from the symptoms, an examination and imaging was enough to start treatment.[13]

ESHRE, 2022

The European guideline of 2022 adopted that position. Laparoscopy is no longer the required first step; a diagnosis can rest on the history, an examination and imaging, and treatment can begin without surgery. The guideline also recognises that much of the diagnosis is the pattern of symptoms over time, and it lists the ones to ask about: pain with periods, chronic pelvic pain, pain with sex, with the bowel and with the bladder, and infertility.[2]

NICE NG73

The UK guideline tells clinicians to suspect endometriosis in anyone presenting with one or more of the following: chronic pelvic pain, period pain that affects daily activities and quality of life, deep pain during or after sex, period-related or cyclical bowel symptoms, period-related or cyclical urinary symptoms, or infertility together with any of these.[3] Every one of those is something a person notices and can write down, with a date, long before anyone examines her.

ACOG, 2026

In March 2026 the American College of Obstetricians and Gynecologists published its own practice guideline, and it says the same in plainer words: a clinical diagnosis made from the symptoms, the history and a physical examination is enough to begin treatment, and surgery is not needed to confirm it first.[4]

Whose record it is

If the diagnosis begins with the history, then the history is evidence, and it belongs to the person who lived it. A dated record of what hurt, when, and how it lined up with periods is what all three guidelines ask a clinician to look for. It is also health data, which the General Data Protection Regulation places in a special category with stricter rules than almost any other kind of information.[21] That is the reason nothing written in Emenla leaves the phone.

How Emenla uses this

What the app does with the evidence:

We record:

Your sentence is kept word for word. Beside it, Emenla prints the clinical term that matches, with the guideline it comes from, so that you and your clinician can compare the two at a glance and disagree if you need to.[2][3][4]

We count:

Each entry is counted against the periods you logged: how many days, which days, how often the pain came with a period and how often it did not. The count is shown as a count, never as a conclusion.

We print:

One page for the appointment: your words, the matching terms, the counts and the dates. It is built on the phone and it stays there unless you choose to share it.

References.

  1. World Health Organization. Endometriosis, fact sheet. who.int/news-room/fact-sheets/detail/endometriosis
  2. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. https://doi.org/10.1093/hropen/hoac009
  3. National Institute for Health and Care Excellence. Endometriosis: diagnosis and management. NICE guideline NG73, 2017, updated 2024. nice.org.uk/guidance/ng73
  4. American College of Obstetricians and Gynecologists. Diagnosis of Endometriosis. Clinical Practice Guideline No. 11, March 2026. acog.org
  5. Scoping review of diagnostic delay in endometriosis, 2024. PubMed Central, PMC11633989. ncbi.nlm.nih.gov/pmc/articles/PMC11633989
  6. Ballard K, Lowton K, Wright J. What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis. Fertil Steril. 2006;86(5):1296-1301. https://doi.org/10.1016/j.fertnstert.2006.04.054
  7. Hudelist G, Fritzer N, Thomas A, et al. Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod. 2012;27(12):3412-3416. https://doi.org/10.1093/humrep/des316
  8. Ghai V, Jan H, Shakir F, Haines P, Kent A. Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol. 2020;40(1):83-89. https://doi.org/10.1080/01443615.2019.1603217
  9. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366-373.e8. https://doi.org/10.1016/j.fertnstert.2011.05.090
  10. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244-1256. https://doi.org/10.1056/NEJMra1810764
  11. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839-852. https://doi.org/10.1016/S0140-6736(21)00389-5
  12. Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750. https://doi.org/10.1136/bmj-2022-070750
  13. Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1-354.e12. https://doi.org/10.1016/j.ajog.2018.12.039
  14. Bullo S. "I feel like I'm being stabbed by a thousand tiny men": the challenges of communicating endometriosis pain. Health (London). 2020;24(5):476-492. https://doi.org/10.1177/1363459318817943
  15. Denny E. Women's experience of endometriosis. J Adv Nurs. 2004;46(6):641-648. https://doi.org/10.1111/j.1365-2648.2004.03055.x
  16. Jones G, Kennedy S, Barnard A, Wong J, Jenkinson C. Development of an endometriosis quality-of-life instrument: the Endometriosis Health Profile-30. Obstet Gynecol. 2001;98(2):258-264. https://doi.org/10.1016/S0029-7844(01)01433-8
  17. Simoens S, Dunselman G, Dirksen C, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292-1299. https://doi.org/10.1093/humrep/des073
  18. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-275. https://doi.org/10.1038/nrendo.2013.255
  19. Nezhat C, Nezhat F, Nezhat C. Endometriosis: ancient disease, ancient treatments. Fertil Steril. 2012;98(6 Suppl):S1-S62. https://doi.org/10.1016/j.fertnstert.2012.08.001
  20. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4):422-469.
  21. Regulation (EU) 2016/679 (General Data Protection Regulation), Article 9: processing of special categories of personal data. eur-lex.europa.eu/eli/reg/2016/679/oj

Reference wording and page numbers were checked against the publishers' records on 2026-08-28. If you find an error, write to hello@emenla.com and it will be corrected.